Inspire Medical Systems (INSP) Cash from Financing Activities (2017 - 2026)

Inspire Medical Systems has reported Cash from Financing Activities for 10 years, with the latest figure at -$7.5 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 91.47% year-over-year to -$7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$103.2 million (up 26.79% YoY) and the FY2025 annual result came in at -$183.4 million, down 250.14% from the prior year.
• Cash from Financing Activities rose to -$7.5 million in Q1 2026 per INSP's latest filing, from -$48.3 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $224.1 million in Q3 2022 and troughed at -$87.8 million in Q1 2025.
• A 5-year average of $335470.6 and a median of $3.0 million in 2022 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities surged 5732.03% in 2022, then tumbled 11527.08% in 2025.
• Over 5 years, Cash from Financing Activities stood at $7.3 million in 2022, then sank by 238.77% to -$10.1 million in 2023, then sank by 593.41% to -$70.1 million in 2024, then surged by 31.12% to -$48.3 million in 2025, then soared by 84.51% to -$7.5 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$7.5 million, -$48.3 million, and -$51.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.